BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ACT201 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ACT201\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07929805-10231@assetmemo.bio
DTSTAMP:20261121T004512Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:ACT201: Phase 1 readout est. (NCT07929805)
DESCRIPTION:ACT201\, phase 1\, Chronic Hepatitis B.\nStudy: ACT201 Injectio
 n in Participants With Chronic Hepatitis B (CHB) on Nucleos(t)Ide Analog T
 herapy - Phase Ib\nEstimated primary completion: February 2027. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/act201#upcoming-events\nRegistr
 y record: https://clinicaltrials.gov/study/NCT07929805
URL:https://assetmemo.bio/drug/act201#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07946757-10231@assetmemo.bio
DTSTAMP:20261121T004512Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:ACT201: Phase 1 readout est. (NCT07946757)
DESCRIPTION:ACT201\, phase 1\, Chronic Hepatitis B.\nStudy: Phase Ib Clinic
 al Trial of ACT201 Injection in Participants With Treatment-Naïve Chronic
  Hepatitis B\nEstimated primary completion: February 2027. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/act201#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07946757
URL:https://assetmemo.bio/drug/act201#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07741461-10231@assetmemo.bio
DTSTAMP:20261121T004512Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:ACT201: Phase 1 readout est. (NCT07741461)
DESCRIPTION:ACT201\, phase 1\, Chronic Hepatitis B.\nStudy: ACT201 Injectio
 n in Healthy Participants and Participants With Chronic Hepatitis B (CHB)\
 nEstimated primary completion: March 2027. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/act201#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07741461
URL:https://assetmemo.bio/drug/act201#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
